Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 45.85 CNY -0.86% Market Closed
Market Cap: 292.5B CNY
Have any thoughts about
Jiangsu Hengrui Pharmaceuticals Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock under the Base Case scenario is 34.84 CNY. Compared to the current market price of 45.85 CNY, Jiangsu Hengrui Pharmaceuticals Co Ltd is Overvalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
34.84 CNY
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jiangsu Hengrui Pharmaceuticals Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Jiangsu Hengrui Pharmaceuticals Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Jiangsu Hengrui Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

45.85 CNY
-0.86%
-0.86%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Jiangsu Hengrui Pharmaceuticals Co Ltd
CN
Pharmaceuticals
Market Cap
292.5B CNY
IPO
Oct 18, 2000
Employees
24 491
China
Market Cap
292.5B CNY
Industry
Pharmaceuticals
IPO
Oct 18, 2000
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Jiangsu Hengrui Pharmaceuticals Co Ltd

Provide an overview of the primary business activities
of Jiangsu Hengrui Pharmaceuticals Co Ltd.

What unique competitive advantages
does Jiangsu Hengrui Pharmaceuticals Co Ltd hold over its rivals?

What risks and challenges
does Jiangsu Hengrui Pharmaceuticals Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide P/S
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide P/E
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide P/OCF
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide P/FCFE
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide P/B
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/S
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/GP
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/EBITDA
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/EBIT
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/OCF
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/FCFF
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide EV/IC
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Show me price targets
for Jiangsu Hengrui Pharmaceuticals Co Ltd made by professional analysts.

What are the Revenue projections
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

How accurate were the past Revenue estimates
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

What are the Net Income projections
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

How accurate were the past Net Income estimates
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

What are the EPS projections
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

How accurate were the past EPS estimates
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

What are the EBIT projections
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

How accurate were the past EBIT estimates
for Jiangsu Hengrui Pharmaceuticals Co Ltd?

Compare the revenue forecasts
for Jiangsu Hengrui Pharmaceuticals Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jiangsu Hengrui Pharmaceuticals Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jiangsu Hengrui Pharmaceuticals Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jiangsu Hengrui Pharmaceuticals Co Ltd compared to its peers.

Compare the P/E ratios
of Jiangsu Hengrui Pharmaceuticals Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jiangsu Hengrui Pharmaceuticals Co Ltd with its peers.

Analyze the financial leverage
of Jiangsu Hengrui Pharmaceuticals Co Ltd compared to its main competitors.

Show all profitability ratios
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide ROE
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide ROA
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide ROIC
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide ROCE
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Gross Margin
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Operating Margin
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Net Margin
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide FCF Margin
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Show all solvency ratios
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide D/E Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide D/A Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Interest Coverage Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Altman Z-Score Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Quick Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Current Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Provide Cash Ratio
for Jiangsu Hengrui Pharmaceuticals Co Ltd.

What is the historical Revenue growth
over the last 5 years for Jiangsu Hengrui Pharmaceuticals Co Ltd?

What is the historical Net Income growth
over the last 5 years for Jiangsu Hengrui Pharmaceuticals Co Ltd?

What is the current Free Cash Flow
of Jiangsu Hengrui Pharmaceuticals Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jiangsu Hengrui Pharmaceuticals Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jiangsu Hengrui Pharmaceuticals Co Ltd

Current Assets 34.8B
Cash & Short-Term Investments 23.3B
Receivables 7.5B
Other Current Assets 4B
Non-Current Assets 13.4B
Long-Term Investments 1.5B
PP&E 7B
Intangibles 4.2B
Other Non-Current Assets 702.3m
Current Liabilities 4.8B
Accounts Payable 1.4B
Accrued Liabilities 128.5m
Short-Term Debt 249m
Other Current Liabilities 3B
Non-Current Liabilities 750.8m
Long-Term Debt 58.3m
Other Non-Current Liabilities 692.5m
Efficiency

Earnings Waterfall
Jiangsu Hengrui Pharmaceuticals Co Ltd

Revenue
26B CNY
Cost of Revenue
-3.9B CNY
Gross Profit
22.1B CNY
Operating Expenses
-16.2B CNY
Operating Income
5.8B CNY
Other Expenses
-392m CNY
Net Income
5.4B CNY

Free Cash Flow Analysis
Jiangsu Hengrui Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jiangsu Hengrui Pharmaceuticals Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive Revenue Growth Forecast
59/100
Profitability
Score

Jiangsu Hengrui Pharmaceuticals Co Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jiangsu Hengrui Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Jiangsu Hengrui Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd

Wall Street analysts forecast Jiangsu Hengrui Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 60.87 CNY with a low forecast of 45.45 CNY and a high forecast of 129.15 CNY.

Lowest
Price Target
45.45 CNY
1% Downside
Average
Price Target
60.87 CNY
33% Upside
Highest
Price Target
129.15 CNY
182% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Jiangsu Hengrui Pharmaceuticals Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jiangsu Hengrui Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock?

The intrinsic value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock under the Base Case scenario is 34.84 CNY.

Is Jiangsu Hengrui Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 45.85 CNY, Jiangsu Hengrui Pharmaceuticals Co Ltd is Overvalued by 24%.

Back to Top